Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

In the new study, the team studied brain imaging, clinical data, and blood markers of angiogenesis, including the family of VEGF growth factors and their receptors. VEGF stands for vascular ...

In diabetic kidney disease, fat accumulates in the kidneys, leading to lipotoxicity and kidney damage. A recently published ...

Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA (fruquintinib) capsules to treat adults with ...

Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering ... tyrosine kinase inhibitor able to inhibit VEGF receptors 1, 2 and 3, PDGF receptors ...

The following is a summary of “How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema,” published in the December 2024 issue of ...

Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on ...

Summit Therapeutics plc (NASDAQ:SMMT) shares, currently trading at $19.03, maintained its Buy rating and $44.00 price target ...

Truist initiated coverage on BioNTech SE (NASDAQ:BNTX), a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc ...